ABEONA THERAPEUT. DL-01 (PCJ) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.113x

Based on the latest financial reports, ABEONA THERAPEUT. DL-01 (PCJ) has a cash flow conversion efficiency ratio of -0.113x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-17.95 Million ≈ $-20.99 Million USD) by net assets (€159.22 Million ≈ $186.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

ABEONA THERAPEUT. DL-01 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how ABEONA THERAPEUT. DL-01's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ABEONA THERAPEUT. DL-01 balance sheet liabilities for a breakdown of total debt and financial obligations.

ABEONA THERAPEUT. DL-01 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ABEONA THERAPEUT. DL-01 ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Northern Ocean Ltd OL:NOL	0.073x
Air Asia Co Ltd TW:2630	0.161x
Xpro India Limited NSE:XPROINDIA	0.021x
Voxel S.A. WAR:VOX	0.074x
Vátryggingafélag Íslands hf IC:SKAGI	0.083x
ST.GEORGE MINING LTD F:S0G	N/A
John Marshall Bancorp Inc NASDAQ:JMSB	0.006x
Bintang Oto Global Tbk PT JK:BOGA	0.031x

Annual Cash Flow Conversion Efficiency for ABEONA THERAPEUT. DL-01 (2021–2025)

The table below shows the annual cash flow conversion efficiency of ABEONA THERAPEUT. DL-01 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see ABEONA THERAPEUT. DL-01 market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€159.22 Million ≈ $186.14 Million	€-76.33 Million ≈ $-89.23 Million	-0.479x	+62.32%
2024-12-31	€44.03 Million ≈ $51.48 Million	€-56.02 Million ≈ $-65.49 Million	-1.272x	+49.04%
2023-12-31	€14.83 Million ≈ $17.33 Million	€-37.01 Million ≈ $-43.27 Million	-2.496x	-53.63%
2022-12-31	€26.76 Million ≈ $31.29 Million	€-43.48 Million ≈ $-50.84 Million	-1.625x	-4.84%
2021-12-31	€42.37 Million ≈ $49.53 Million	€-65.67 Million ≈ $-76.77 Million	-1.550x	--

About ABEONA THERAPEUT. DL-01

F:PCJ Germany Biotechnology

Market Cap

$305.58 Million

€261.38 Million EUR

Market Cap Rank

#15318 Global

#1496 in Germany

Share Price

€4.60

Change (1 day)

-1.01%

52-Week Range

€3.56 - €6.10

All Time High

€17.73